Motero Carrasco J
Del Centro Periférico de Especialidades Virgen de la Cinta, Huelva, España.
Arch Inst Cardiol Mex. 1997 Jan-Feb;67(1):29-37.
To compare the antihypertensive efficacy of lisinopril (L) versus enalapril (E) given 20 mg once daily for the treatment of mild to moderate arterial hypertension (diastolic blood pressure between 90-114 mm Hg) using ambulatory blood pressure monitoring (ABPM). This study also investigated the tolerance and changes in haematological or biochemical parameters with both drugs.
One hundred patients (men and women) with a range of age between 18 to 75 years were included in this open, randomised study to assess the hypotensive efficacy of L versus E after 2 months of treatment, using ambulatory blood pressure monitoring. To study data obtained from ABPM Mc Call curves were used and statistical analysis was made using SPSS program. Covariance and Chi-square test were used for the comparative analysis of different variables, considering as significant value p < 0.05. Graphics were made using HG 3.0 version. All patients gave their informed consent to participate in the study. The protocol was approved by the Ethical Committee of the Clinic Hospital.
Systolic blood pressure (SBP) decreased from 179.00 to 156.96 mm Hg in the Lisinopril group (p < 0.001) and from 176.65 to 149.20 mm Hg in the Enalapril group (p < 0.001). Diastolic blood pressure (DBP) decreased from 104.96 to 89.94 mm Hg in the L group (p < 0.001) and from 104.16 to 86.20 mm Hg in the E group (p < 0.001). Using ABPM mean SBP daily decreased from 163.86 to 132.26 mm Hg with L (p < 0.001) and from 156.65 to 136.18 mm Hg with E (p < 0.001). Mean DBP daily decreased from 99.23 to 87.51 mm Hg with L (p < 0.001) and from 96.55 to 87.24 with E (p < 0.001). Decreases were found from total cholesterol in both groups (from 218.46 to 207.29 mg/dl with L and from 220.59 to 205.19 mg/dl with E) (p < 0.05) and Cholesterol-LDL in the E group (150.44 to 138.88) (p < 0.05).
Both drugs produce a fall of blood pressure in mild-to-moderate hypertension, although using ABPM this fall is more significant with. According to McCall index 73.45% of patients in the Lisinopril group and 69.26% of Enalapril group controlled their hypertension, there was a difference found between BP values obtained in the clinic and those obtained using ABPM.
采用动态血压监测(ABPM)比较赖诺普利(L)与依那普利(E)每日一次服用20mg治疗轻度至中度动脉高血压(舒张压90 - 114mmHg)的降压疗效。本研究还调查了两种药物的耐受性以及血液学或生化参数的变化。
本开放性随机研究纳入了100名年龄在18至75岁之间的患者(男女均有),使用动态血压监测评估治疗2个月后L与E的降压疗效。为研究从ABPM获得的数据,使用了麦考尔曲线,并使用SPSS程序进行统计分析。采用协方差和卡方检验对不同变量进行比较分析,将p < 0.05视为显著值。使用HG 3.0版本制作图表。所有患者均签署知情同意书参与本研究。该方案已获临床医院伦理委员会批准。
赖诺普利组收缩压(SBP)从179.00mmHg降至156.96mmHg(p < 0.001),依那普利组从176.65mmHg降至149.20mmHg(p < 0.001)。赖诺普利组舒张压(DBP)从104.96mmHg降至89.94mmHg(p < 0.001),依那普利组从104.16mmHg降至86.20mmHg(p < 0.001)。使用ABPM,赖诺普利组平均每日SBP从163.86mmHg降至132.26mmHg(p < 0.001),依那普利组从156.65mmHg降至136.18mmHg(p < 0.001)。赖诺普利组平均每日DBP从99.23mmHg降至87.51mmHg(p < 0.001),依那普利组从96.55mmHg降至87.24mmHg(p < 0.001)。两组总胆固醇均有所下降(赖诺普利组从218.46mg/dl降至207.29mg/dl,依那普利组从220.59mg/dl降至205.19mg/dl)(p < 0.05),依那普利组低密度脂蛋白胆固醇(LDL - C)也有所下降(从150.44降至138.88)(p < 0.05)。
两种药物均可使轻度至中度高血压患者血压下降,不过使用ABPM时,赖诺普利组血压下降更为显著。根据麦考尔指数,赖诺普利组73.45%的患者和依那普利组69.26%的患者控制了高血压,临床测得的血压值与使用ABPM测得的血压值存在差异。